Weill Medical College Of Cornell
University
CAGE Code: 1UMU6
NCAGE Code: 1UMU6
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 060217502
Summary
Weill Medical College Of Cornell, University is an Active Commercial Supplier with the Cage Code 1UMU6 and is tracked by Dun & Bradstreet under DUNS Number 060217502..
Address
575 Lexington Ave Fl 9
New York NY 10022-6145
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Tempo Sense Inc Trumeter Co Inc Doctors Without Borders Lorrillard Tobacco Co Industrial Scientific Co Amerotron Corp Fuller George A Co Div Of Northrop Standard Industries Inc M Rosenblatt & Son Inc American Business Machines Inc Associated American Trading Div Of Syrkus And Guttman Inc Rhi Entertainment Inc A B C Inc Play Co Toys Inc Buttling Padgett Co Inc Mutual Electric And Machine Corp Vulcan Machine And Mfg Inc Anchor Steel Co National Ignition Mfg Co Inc
Frequently Asked Questions (FAQ) for CAGE 1UMU6
- What is CAGE Code 1UMU6?
- 1UMU6 is the unique identifier used by NATO Organizations to reference the physical entity known as Weill Medical College Of Cornell University located at 575 Lexington Ave Fl 9, New York NY 10022-6145, United States.
- Who is CAGE Code 1UMU6?
- 1UMU6 refers to Weill Medical College Of Cornell University located at 575 Lexington Ave Fl 9, New York NY 10022-6145, United States.
- Where is CAGE Code 1UMU6 Located?
- CAGE Code 1UMU6 is located in New York, NY, USA.
Contracting History for CAGE 1UMU6 Most Recent 25 Records
- 75D30121C10170
- Tuberculosis Trials And Consortium Services
- 30 Dec 2021
- Tuberculosis Trials And Consortium Services
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $1,052,451.00
- Department Of Health And Human Services (Hhs)
- 75D30121C10170
- Tuberculosis Trials And Consortium Services
- 30 Nov 2023
- Tuberculosis Trials And Consortium Services
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $2,170,840.24
- Department Of Health And Human Services (Hhs)
- 75D30121C10170
- Tuberculosis Trials And Consortium Services
- 21 Jul 2022
- Tuberculosis Trials And Consortium Services
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $1,052,451.00
- Department Of Health And Human Services (Hhs)
- 75D30121C10170
- Tuberculosis Trials And Consortium Services
- 2 Nov 2022
- Tuberculosis Trials And Consortium Services
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $1,604,031.00
- Department Of Health And Human Services (Hhs)
- 75D30121C10170
- Tuberculosis Trials And Consortium Services
- 21 Jul 2022
- Tuberculosis Trials And Consortium Services
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $1,052,451.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00140
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- 30 Nov 2021
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $994,896.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00140
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- 7 Oct 2022
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $994,896.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00140
- Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- 29 Nov 2022
- Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $994,896.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00140
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- 4 Mar 2022
- Eo 14042: Baa-19-00123 - Pmwp#132 - Development Of Rabbit Animal Models Of Ventilator-Associated Bacterial Pneumonia Produced By Carbapenem-Resistant Pseudomonas Aeruginosa And Acinetobacter Baumannii
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $994,896.00
- Department Of Health And Human Services (Hhs)
- 75N91018F00005
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- 22 Aug 2023
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $891,983.59
- Department Of Health And Human Services (Hhs)
- 75F40119P10293
- Human Whole Genome Sequencing
- 24 Jun 2019
- Human Whole Genome Sequencing
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $149,600.00
- Department Of Health And Human Services (Hhs)
- 75N91018F00005
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- 31 Aug 2022
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $894,832.00
- Department Of Health And Human Services (Hhs)
- HHSN261201500039I
- Efficacy Idiqs- Increase Programmatic Maximum
- 9 Jun 2022
- Efficacy Idiqs- Increase Programmatic Maximum
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N93023P01283
- Dataset Deliveable Population-Based Epidemiologic Study Of New York, Ny Pertaining To Non-Tuberculous Mycobacterial Pulmonary Disease
- 14 Sep 2023
- Dataset Deliveable Population-Based Epidemiologic Study Of New York, Ny Pertaining To Non-Tuberculous Mycobacterial Pulmonary Disease
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $18,000.00
- Department Of Health And Human Services (Hhs)
- HHSN261201500039I
- Efficacy Idiqs- Increase Programmatic Maximum
- 19 Jun 2018
- Efficacy Idiqs- Increase Programmatic Maximum
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- HHSN26100004
- Anti-Fusobacterium Nucleatum Vaccine For Colorectal Cancer Immunoprevention; Pop 09/19/2016 - 09/07/2022
- 22 May 2023
- Anti-Fusobacterium Nucleatum Vaccine For Colorectal Cancer Immunoprevention; Pop 09/19/2016 - 09/07/2022
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,246,582.34
- Department Of Health And Human Services (Hhs)
- HHSN26100006
- Igf::Ot::Igf Base Contract Title: Preclinical In Vitro And In Vivo Agent Development Assays, Task Order Title: A Polyvalent Vaccine Against Fusion Proteins Observed In Solid Tumors, Period Of Performance: August 29, 2014 Through August 28, 2016
- 22 Aug 2014
- Igf::Ot::Igf Base Contract Title: Preclinical In Vitro And In Vivo Agent Development Assays, Task Order Title: A Polyvalent Vaccine Against Fusion Proteins Observed In Solid Tumors, Period Of Performance: August 29, 2014 Through August 28, 2016
- Nih, Nci, Od Om Oa Ofc Acquisitions
- Department Of Health And Human Services (Hhs)
- $455,960.00
- Department Of Health And Human Services (Hhs)
- 75N91018F00005
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- 16 Mar 2022
- Frameshift Peptide Vaccine For The Prevention Lynch Syndrome-Associated Gastrointestinal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $894,832.00
- Department Of Health And Human Services (Hhs)
- HHSN26100003
- Testing Of Combination Immuno And Chemoprevention Strategies For Lynch Syndrome Gastrointestinal Cancer Pop 9/24/15 - 9/23/19
- 14 Sep 2022
- Testing Of Combination Immuno And Chemoprevention Strategies For Lynch Syndrome Gastrointestinal Cancer Pop 9/24/15 - 9/23/19
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $828,445.00
- Department Of Health And Human Services (Hhs)
- HHSN26100004
- Anti-Fusobacterium Nucleatum Vaccine For Colorectal Cancer Immunoprevention; Pop 09/19/2016 - 09/07/2022
- 17 Aug 2021
- Anti-Fusobacterium Nucleatum Vaccine For Colorectal Cancer Immunoprevention; Pop 09/19/2016 - 09/07/2022
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,247,410.25
- Department Of Health And Human Services (Hhs)